[144] Esperion Therapeutics, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 filed for ESPR insider Benjamin Halladay proposes to sell 7,046 shares of common stock on or about 09/17/2025. The shares were acquired on 09/15/2025 upon restricted stock vesting and are being sold as compensation. The filing lists an aggregate market value of $19,788.69 for the proposed sale versus 201,622,825 shares outstanding, indicating the sale is a very small fraction of the company. The filer previously sold 7,229 shares on 06/17/2025 for $8,329.25 and 11 shares on 07/17/2025 for $12.27. The signer certifies no undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Insider plans to sell recently vested shares; size is immaterial relative to outstanding shares.

The proposed sale of 7,046 shares following a 09/15/2025 restricted stock vesting is consistent with routine insider liquidity from compensation. At an aggregate market value of $19,788.69 against 201,622,825 shares outstanding, this transaction is immaterial to ESPR's market capitalization and unlikely to affect share supply materially. Prior small sales in June and July 2025 show some ongoing insider liquidity but not a pattern of large disposals. From an analyst perspective, this filing is a routine disclosure rather than a signal of corporate distress.

Corporate Governance Expert

TL;DR: Disclosure follows Rule 144 requirements; vesting-based sale aligns with standard executive compensation practices.

The filing documents a sale tied to restricted stock vesting with payment characterized as compensation, and includes the customary representation about material information. The timing—notice of proposed sale two days after vesting—matches common governance practices for insiders seeking liquidity. No trading-plan declaration is provided on the form. For governance review, the filing appears compliant and transparent, but stakeholders may note the recent small-scale sales in June and July 2025.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	7046	19788.69	201622825	09/17/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/15/2025	Restricted Stock Vesting	Issuer			7046	09/15/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Benjamin Halladay 3891 Ranchero Drive Suite 150 Ann Arbor MI 48108	Common	06/17/2025	7229	8329.25
Benjamin Halladay 3891 Ranchero Drive Suite 150 Ann Arbor MI 48108	Common	07/17/2025	11	12.27

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the ESPR Form 144 filed by Benjamin Halladay report?

It reports a proposed sale of 7,046 ESPR common shares, acquired via restricted stock vesting on 09/15/2025, with an approximate sale date of 09/17/2025.

How much are the shares in the proposed ESPR sale worth?

The aggregate market value is $19,788.69 for the 7,046 shares listed in the filing.

How large is the proposed sale relative to ESPR's outstanding shares?

The sale is very small: 7,046 shares versus 201,622,825 shares outstanding as stated in the filing.

Has the filer sold ESPR shares recently?

Yes. The filing discloses sales of 7,229 shares on 06/17/2025 for $8,329.25 and 11 shares on 07/17/2025 for $12.27.

Was the acquisition of these shares part of compensation?

Yes. The securities were acquired on 09/15/2025 via restricted stock vesting and the payment is characterized as compensation.